Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Onset of Sensory Blockade in Ankle Block With Mepivacaine vs Bupivacaine
NCT05425979Phase 4Enrolling by invitation
- Sponsor
- Mayo Clinic
- Start
- Mar 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial comparing Mepivacaine group with Bupivacaine group (2 arms). Primary endpoint: Onset of sensory Blockage at 20 minutes. Started Mar 2024; status: enrolling by invitation.
02
Drugs
mepivacainebupivacaine
Beyond the preview
Go deeper on NCT05425979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05425979.